Logo image of UAMY

UNITED STATES ANTIMONY CORP (UAMY) Stock Fundamental Analysis

NYSEARCA:UAMY - NYSE Arca - US9115491030 - Common Stock - Currency: USD

2.42  -0.15 (-5.84%)

Premarket: 2.44 +0.02 (+0.83%)

Fundamental Rating

5

Taking everything into account, UAMY scores 5 out of 10 in our fundamental rating. UAMY was compared to 153 industry peers in the Metals & Mining industry. UAMY has a great financial health rating, but its profitability evaluates not so good. UAMY is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

UAMY had negative earnings in the past year.
UAMY had a positive operating cash flow in the past year.
UAMY had negative earnings in 4 of the past 5 years.
UAMY had negative operating cash flow in 4 of the past 5 years.
UAMY Yearly Net Income VS EBIT VS OCF VS FCFUAMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

UAMY's Return On Assets of -5.02% is on the low side compared to the rest of the industry. UAMY is outperformed by 62.09% of its industry peers.
With a Return On Equity value of -6.08%, UAMY perfoms like the industry average, outperforming 43.14% of the companies in the same industry.
Industry RankSector Rank
ROA -5.02%
ROE -6.08%
ROIC N/A
ROA(3y)-8.85%
ROA(5y)-10.39%
ROE(3y)-9.93%
ROE(5y)-15.31%
ROIC(3y)N/A
ROIC(5y)N/A
UAMY Yearly ROA, ROE, ROICUAMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

UAMY has a better Gross Margin (23.21%) than 63.40% of its industry peers.
UAMY's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for UAMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.95%
GM growth 5YN/A
UAMY Yearly Profit, Operating, Gross MarginsUAMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

8

2. Health

2.1 Basic Checks

UAMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
UAMY has more shares outstanding than it did 1 year ago.
UAMY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UAMY is higher compared to a year ago.
UAMY Yearly Shares OutstandingUAMY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
UAMY Yearly Total Debt VS Total AssetsUAMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 27.46 indicates that UAMY is not in any danger for bankruptcy at the moment.
UAMY's Altman-Z score of 27.46 is amongst the best of the industry. UAMY outperforms 86.93% of its industry peers.
The Debt to FCF ratio of UAMY is 0.18, which is an excellent value as it means it would take UAMY, only 0.18 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.18, UAMY belongs to the best of the industry, outperforming 92.81% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that UAMY is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.01, UAMY is doing good in the industry, outperforming 79.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.18
Altman-Z 27.46
ROIC/WACCN/A
WACC10%
UAMY Yearly LT Debt VS Equity VS FCFUAMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

UAMY has a Current Ratio of 5.16. This indicates that UAMY is financially healthy and has no problem in meeting its short term obligations.
UAMY has a Current ratio of 5.16. This is amongst the best in the industry. UAMY outperforms 83.66% of its industry peers.
A Quick Ratio of 4.85 indicates that UAMY has no problem at all paying its short term obligations.
UAMY has a Quick ratio of 4.85. This is amongst the best in the industry. UAMY outperforms 83.66% of its industry peers.
Industry RankSector Rank
Current Ratio 5.16
Quick Ratio 4.85
UAMY Yearly Current Assets VS Current LiabilitesUAMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

7

3. Growth

3.1 Past

UAMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.05%, which is quite impressive.
Looking at the last year, UAMY shows a very strong growth in Revenue. The Revenue has grown by 71.84%.
Measured over the past years, UAMY shows a quite strong growth in Revenue. The Revenue has been growing by 12.56% on average per year.
EPS 1Y (TTM)73.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.09%
Revenue 1Y (TTM)71.84%
Revenue growth 3Y24.46%
Revenue growth 5Y12.56%
Sales Q2Q%312.64%

3.2 Future

UAMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 174.77% yearly.
Based on estimates for the next years, UAMY will show a very strong growth in Revenue. The Revenue will grow by 99.09% on average per year.
EPS Next Y250%
EPS Next 2Y300%
EPS Next 3Y247.6%
EPS Next 5Y174.77%
Revenue Next Year291.19%
Revenue Next 2Y182.53%
Revenue Next 3Y143.61%
Revenue Next 5Y99.09%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UAMY Yearly Revenue VS EstimatesUAMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
UAMY Yearly EPS VS EstimatesUAMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UAMY. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 79.08, UAMY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UAMY indicates a slightly more expensive valuation: UAMY is more expensive than 60.78% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. UAMY is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 79.08
UAMY Price Earnings VS Forward Price EarningsUAMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

UAMY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 159.45
EV/EBITDA N/A
UAMY Per share dataUAMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

UAMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UAMY's earnings are expected to grow with 247.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y300%
EPS Next 3Y247.6%

0

5. Dividend

5.1 Amount

UAMY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UNITED STATES ANTIMONY CORP

NYSEARCA:UAMY (5/28/2025, 8:05:26 PM)

Premarket: 2.44 +0.02 (+0.83%)

2.42

-0.15 (-5.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners20.62%
Inst Owner Change29.05%
Ins Owners9.85%
Ins Owner Change1.57%
Market Cap285.37M
Analysts82
Price Target4.55 (88.02%)
Short Float %10.22%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)60.33%
PT rev (3m)70%
EPS NQ rev (1m)100%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-45.45%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)3.54%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)32.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 79.08
P/S 19.1
P/FCF 159.45
P/OCF 128.53
P/B 9.98
P/tB 9.98
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.03
Fwd EY1.26%
FCF(TTM)0.02
FCFY0.63%
OCF(TTM)0.02
OCFY0.78%
SpS0.13
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.02%
ROE -6.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.21%
FCFM 11.98%
ROA(3y)-8.85%
ROA(5y)-10.39%
ROE(3y)-9.93%
ROE(5y)-15.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.95%
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.18
Debt/EBITDA N/A
Cap/Depr 39.66%
Cap/Sales 2.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.16
Quick Ratio 4.85
Altman-Z 27.46
F-Score5
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)129.62%
Cap/Depr(5y)97.98%
Cap/Sales(3y)12.03%
Cap/Sales(5y)9.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.09%
EPS Next Y250%
EPS Next 2Y300%
EPS Next 3Y247.6%
EPS Next 5Y174.77%
Revenue 1Y (TTM)71.84%
Revenue growth 3Y24.46%
Revenue growth 5Y12.56%
Sales Q2Q%312.64%
Revenue Next Year291.19%
Revenue Next 2Y182.53%
Revenue Next 3Y143.61%
Revenue Next 5Y99.09%
EBIT growth 1Y65.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year255.7%
EBIT Next 3Y254.91%
EBIT Next 5Y175.64%
FCF growth 1Y128.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y146.74%
OCF growth 3YN/A
OCF growth 5YN/A